Scholars Central

Conference abstractPublished 27 Sep 2021

Dementia - an auditory outlook

Authors: Parveen Bazard

University of South Florida, USA

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

According to the 2020 Lancet commission on dementia, hearing loss is the top modifiable risk factor against dementia, and risk of dementia worsens with every 10 dB of hearing loss. The commission also found an increased dementia risk for those not using hearing aids and, it recommends hearing aids to reduce the risk of cognitive decline and dementia. So, hearing loss treatment/management could be a way of significantly lowering the risk of dementia among our aged population. Hearing loss is an invisible disability and is among the top three medical chronic conditions among our aged population. Apart from contributing to cognitive decline, hearing loss leads to social isolation, dependence on others and anxiety. Current treatments like hearing aids and cochlear implants often help improve the daily life of people with hearing loss. There is still no drug available to prevent/treat it. Recently, we have established that aldosterone – a natural occurring mineralocorticoid hormone has potential to treat certain aspects of age-related hearing loss in aging mice. Animals were treated with subcutaneous time-release pellets for four months. A therapeutic effect was mediated via induced protein enhancement of Na-K-Cl and Na-K-ATPase – two key ion transporters that decline in the aging inner ear. Our clinical study revealed that higher serum aldosterone levels are associated with better hearing in elderly. Though not FDA-approved yet, it is likely that aldosterone will play a significant role in drug development for hearing loss. In sum, efforts to address the concerns of hearing loss – both in terms of drug development and alternative technologies for cochlear implants (i.e., new stimulation techniques), could significantly help to prevent dementia and other age linked cognitive deficits.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • SubjectNeuroscience & Neurology
  • BylineArticles whose byline prints “Parveen Bazard”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels